Evidence map›Paper›PMID 33848463›Full record

ArticleCell2021

Kinase-mediated RAS signaling via membraneless cytoplasmic protein granules.

Asmin Tulpule, Juan Guan, Dana S Neel, Hannah R Allegakoen, Yone Phar Lin, David Brown, Yu-Ting Chou, Ann Heslin, Nilanjana Chatterjee, Shriya Perati and 10 more

Open access · hybridAbstract read
In one paragraph

Article in Cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 120 papers.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

120 citing papers in PubMed, 180 citations in OpenAlex.

  1. Article
  2. Review
  3. Fusion protein condensate formation via coiled-coil domains.Protein science : a publication of the Protein Society · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. α, δ‑ACS pharmacology & translational science · 2025
    Article
  20. Article

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 1 country.

Asmin TulpuleDivision of Pediatric Hematology/Oncology, UCSF, San Francisco, CA 94143, USA.
Juan GuanDepartment of Pharmaceutical Chemistry, UCSF, San Francisco, CA 94143, USA; Department of Physics, University of Florida, Gainesville, FL 32611, USA.
Dana S NeelDepartment of Medicine, Division of Hematology and Oncology, UCSF, San Francisco, CA 94143, USA.
Hannah R AllegakoenDivision of Pediatric Hematology/Oncology, UCSF, San Francisco, CA 94143, USA.
Yone Phar LinDivision of Pediatric Hematology/Oncology, UCSF, San Francisco, CA 94143, USA.
David BrownDepartment of Pharmaceutical Chemistry, UCSF, San Francisco, CA 94143, USA.
Yu-Ting ChouDepartment of Medicine, Division of Hematology and Oncology, UCSF, San Francisco, CA 94143, USA.
Ann HeslinDivision of Pediatric Hematology/Oncology, UCSF, San Francisco, CA 94143, USA.
Nilanjana ChatterjeeDepartment of Medicine, Division of Hematology and Oncology, UCSF, San Francisco, CA 94143, USA.
Shriya PeratiDivision of Pediatric Hematology/Oncology, UCSF, San Francisco, CA 94143, USA.
Shruti MenonDivision of Pediatric Hematology/Oncology, UCSF, San Francisco, CA 94143, USA.
Tan A NguyenDepartment of Pathology and Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA 94143, USA.
Jayanta DebnathDepartment of Pathology and Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA 94143, USA.
Alejandro D RamirezDepartment of Pharmaceutical Chemistry, UCSF, San Francisco, CA 94143, USA.
Xiaoyu ShiDepartment of Pharmaceutical Chemistry, UCSF, San Francisco, CA 94143, USA.
Bin YangDepartment of Pharmaceutical Chemistry, UCSF, San Francisco, CA 94143, USA.
Siyu FengUC Berkeley-UCSF Graduate Program in Bioengineering, UCSF, San Francisco, CA 94143, USA.
Suraj MakhijaDepartment of Pathology and Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA 94143, USA.
Bo HuangDepartment of Pharmaceutical Chemistry, UCSF, San Francisco, CA 94143, USA; Department of Biochemistry and Biophysics, UCSF, San Francisco, CA 94143, USA; Chan Zuckerberg Biohub, San Francisco, CA 94158, USA. Electronic address: bo.huang@ucsf.edu.
Trever G BivonaDepartment of Medicine, Division of Hematology and Oncology, UCSF, San Francisco, CA 94143, USA. Electronic address: trever.bivona@ucsf.edu.
University of California, San Francisco · USUCSF Helen Diller Family Comprehensive Cancer Center · USChan Zuckerberg Initiative (United States) · USUniversity of California, Berkeley · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007618 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDERSON, MARK S · 1985 to 2020
$29.6M
Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human DiseaseRM1HG009490 · NHGRI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI Brittany S. Adamson, Martin Joseph Ankrah Aryee · 2017 to 2026
$22.7M
UCSF Project 1U54CA224081 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Trever G Bivona, Jack Roth · 2017 to 2026
$12.9M
Molecular and Cellular Mechanisms in CancerT32CA108462 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GOGA, ANDREI · 2004 to 2024
$10.4M
Transcellular epigenetic regulation by ex-small RNA in C. elegantU19CA179512 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BLELLOCH, ROBERT · 2013 to 2017
$7.4M
Research Training in Childhood CancerT32CA128583 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Eric Alejandro Sweet-Cordero · 2007 to 2026
$6.0M
Autophagy in Adhesion and MetastasisR01CA126792 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jayanta Debnath · 2009 to 2026
$5.3M
The Cancer Target Discovery and Development Network at UCSFU01CA217882 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BANDYOPADHYAY, SOURAV, BIVONA, TREVER G · 2017 to 2021
$5.2M
Characterization of YAP as a rational companion target in lung cancerR01CA204302 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Trever G Bivona · 2017 to 2026
$3.7M
Rational Combined Inhibition of NF-kB and EGFR to Optimize Lung Cancer TreatmentR01CA169338 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BIVONA, TREVER G · 2013 to 2023
$3.4M
Mapping endogenous protein dynamics in living cellsR01GM131641 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Bo Huang · 2019 to 2026
$2.6M
(PQ7) Defining a new mode of RAS signaling in cancer from cytoplasmic protein granulesR01CA231300 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BIVONA, TREVER G, HUANG, BO · 2019 to 2023
$2.3M
NCI NIH HHS F30 CA210444NCI NIH HHS R01 CA126792NCI NIH HHS R01 CA169338NCI NIH HHS R01 CA204302NCI NIH HHS R01 CA211052NCI NIH HHS R01 CA213775NCI NIH HHS R01 CA231300NCI NIH HHS T32 CA108462NCI NIH HHS T32 CA128583NCI NIH HHS U01 CA217882NCI NIH HHS U19 CA179512NCI NIH HHS U54 CA224081NHGRI NIH HHS RM1 HG009490NIGMS NIH HHS K99 GM126136NIGMS NIH HHS R00 GM126136NIGMS NIH HHS R01 GM124334NIGMS NIH HHS R01 GM131641NIGMS NIH HHS R21 GM129652NIGMS NIH HHS T32 GM007618
6 · The paper itself

Abstract

Receptor tyrosine kinase (RTK)-mediated activation of downstream effector pathways such as the RAS GTPase/MAP kinase (MAPK) signaling cascade is thought to occur exclusively from lipid membrane compartments in mammalian cells. Here, we uncover a membraneless, protein granule-based subcellular structure that can organize RTK/RAS/MAPK signaling in cancer. Chimeric (fusion) oncoproteins involving certain RTKs including ALK and RET undergo de novo higher-order assembly into membraneless cytoplasmic protein granules that actively signal. These pathogenic biomolecular condensates locally concentrate the RAS activating complex GRB2/SOS1 and activate RAS in a lipid membrane-independent manner. RTK protein granule formation is critical for oncogenic RAS/MAPK signaling output in these cells. We identify a set of protein granule components and establish structural rules that define the formation of membraneless protein granules by RTK oncoproteins. Our findings reveal membraneless, higher-order cytoplasmic protein assembly as a distinct subcellular platform for organizing oncogenic RTK and RAS signaling.

Indexed as

Adaptor Proteins, Signal TransducingBiomolecular CondensatesCytoplasmic GranulesEnzyme ActivationGRB2 Adaptor ProteinHEK293 CellsHumansNeoplasmsOncogene Proteins, Fusionras ProteinsSignal TransductionSOS1 ProteinAdaptor Proteins, Signal TransducingEML4-ALK fusion protein, humanGAB1 protein, humanGRB2 Adaptor ProteinGRB2 protein, humanOncogene Proteins, Fusionras ProteinsSOS1 ProteinSOS1 protein, humanALKanaplastic lymphoma kinasebiomolecular condensategene fusionkinaseMAPKprotein granuleRASreceptor tyrosine kinaseRET

Identifiers

PMID33848463
PMCPMC8127962
OpenAlexW3155633297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.